Adler Brittany, Hummers Laura K, Pasricha P Jay, McMahan Zsuzsanna H
Division of Rheumatology.
Division of Gastroenterology and Hepatology, Johns Hopkins University, Baltimore, MD, USA.
Rheumatology (Oxford). 2022 Nov 2;61(11):4503-4508. doi: 10.1093/rheumatology/keac074.
Gastroparesis is a common complication of SSc. We sought to determine the degree of overlap between gastroparesis and dysmotility in other areas of the gut, correlate our findings with gastrointestinal (GI) symptoms, and examine associations between gastroparesis and SSc features.
Whole-gut scintigraphy was performed on SSc patients who were enrolled in the Johns Hopkins Scleroderma Cohort, for whom detailed longitudinal clinical and serologic data are collected. A subset of patients completed the University of California Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument 2.0 (UCLA GIT 2.0) to quantify their GI symptoms. We examined associations between the presence and severity of gastroparesis, GI symptoms, and SSc clinical features.
Ninety-seven SSc patients with and without GI symptoms underwent whole-gut scintigraphy and completed the gastric emptying study. Of the 97, 34 (35%) met criteria for gastroparesis. Of the measures assessed, delayed liquid emptying captured more patients with delayed gastric transit than delayed solid emptying (74% vs 55%), and percentage liquid emptying correlated best with GIT Reflux (ρ = -0.33, P = 0.01) and Distension (ρ = -0.30, P = 0.03) scores. Of 33 patients with gastroparesis, 30 (91%) had abnormal transit in other areas of the GI tract. Higher anti-centromere protein B (CENP-B) titres correlated with slower gastric emptying (ρ = -0.26, P = 0.03), but no specific clinical features of SSc were associated with gastroparesis.
Gastric emptying of liquids when given alongside solids may be more sensitive and provide a more clinically relevant measure of gastroparesis in SSc than solid gastric emptying or liquid gastric emptying alone. SSc patients with gastroparesis frequently have dysmotility in other areas of the GI tract, underscoring the need for whole-gut scintigraphy to evaluate the entire gut.
胃轻瘫是系统性硬化症(SSc)的常见并发症。我们试图确定胃轻瘫与肠道其他部位运动障碍之间的重叠程度,将我们的研究结果与胃肠道(GI)症状相关联,并研究胃轻瘫与SSc特征之间的关联。
对参加约翰霍普金斯硬皮病队列研究的SSc患者进行全肠道闪烁扫描,收集这些患者详细的纵向临床和血清学数据。一部分患者完成了加利福尼亚大学洛杉矶分校硬皮病临床试验联盟胃肠道仪器2.0(UCLA GIT 2.0),以量化他们的GI症状。我们研究了胃轻瘫的存在和严重程度、GI症状与SSc临床特征之间的关联。
97例有或无GI症状的SSc患者接受了全肠道闪烁扫描并完成了胃排空研究。在这97例患者中,34例(35%)符合胃轻瘫标准。在所评估的指标中,与固体排空延迟相比,液体排空延迟能发现更多胃传输延迟的患者(74%对55%),并且液体排空百分比与GIT反流(ρ = -0.33,P = 0.01)和扩张(ρ = -0.30,P = 0.03)评分的相关性最佳。在33例胃轻瘫患者中,30例(91%)在胃肠道其他部位存在传输异常。较高的抗着丝点蛋白B(CENP - B)滴度与胃排空减慢相关(ρ = -0.26,P = 0.03),但SSc的任何特定临床特征均与胃轻瘫无关。
与固体同时给予时的液体胃排空可能比单独的固体胃排空或液体胃排空更敏感,并且能为SSc患者的胃轻瘫提供更具临床相关性的测量方法。患有胃轻瘫的SSc患者在胃肠道其他部位经常存在运动障碍,这突出了进行全肠道闪烁扫描以评估整个肠道的必要性。